The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
Selected proposals in the innovation challenge will receive funding to develop transformative ideas, tools, and approaches to strengthen early diagnosis and improve patient outcomes
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Olaparib is indicated for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers
Subscribe To Our Newsletter & Stay Updated
